Although direct cross-comparison remains difficult, these statistical values were considered higher than previously known laboratory prognostic biomarkers for PAD patients, such as D-dimer (RR: 2.22), hs-cTnT (RR: 3.1), adiponectin (RR: 1.99), and fibrinogen (RR: 2.08) [26–28]. The gene discussed is TNNT2; the disease is peripheral arterial disease.